BioCentury | Dec 17, 2018
Company News

Management tracks: Vertex’s Graney joins Generation Bio

...He is succeeded as president and CEO by David Zaccardelli, who was acting CEO of Cempra Inc....
BioCentury | Jun 1, 2018
Financial News

Melinta closes $123.2M follow-on

...year. Melinta became a publicly traded company in November 2017 via a reverse merger with Cempra Inc....
BioCentury | May 24, 2018
Financial News

Melinta raises $110M in follow-on

...year. Melinta became a publicly traded company in November 2017 via a reverse merger with Cempra Inc....
BioCentury | Jan 31, 2018
Company News

Management tracks: Ipsen, Dragonfly

...disease company Dova Pharmaceuticals Inc. (NASDAQ:DOVA) hired Mark Hahn as CFO. He was CFO of Cempra Inc....
BioCentury | Nov 2, 2017
Company News

Management tracks: Melinta, Lundbeck

...Bluth was EVP of investor relations and corporate communications at Cempra Inc. (NASDAQ:CEMP). Melinta is acquiring Cempra...
BioCentury | Aug 11, 2017
Company News

Melinta goes public by acquiring majority of Cempra

...found a path to becoming public by acquiring a majority stake of fellow infectious company Cempra Inc....
...shareholders will own approximately 52% of the combined company; Cempra shareholders will own the remainder. Cempra...
...companies said Cempra is looking for non-dilutive funding to support a safety trial for Solithera. Cempra Inc....
BioCentury | Aug 9, 2017
Company News

Melinta goes public by acquiring majority of Cempra

...found a path to becoming public by acquiring a majority stake of fellow infectious company Cempra Inc....
...shareholders will own approximately 52% of the combined company; Cempra shareholders will own the remainder. Cempra...
...trial for Solithera. Cempra lost $0.15 to $3.65 on Wednesday. Elizabeth S. Eaton IV delafloxacin IV Solithera Oral delafloxacin Oral Solithera Cempra Inc. Melinta...
BioCentury | May 19, 2017
Clinical News

Cempra withdraws Solithera MAA

...EMA will require additional data for approval. FDA issued complete response letters in December for Cempra’s...
...company plans to resubmit both applications with the additional data requested by FDA. In February, Cempra...
...letter and discussions with FDA (see BioCentury, March 6 ). Solithera is a fluoroketolide/macrolide antibiotic. Cempra...
BioCentury | Apr 7, 2017
Finance

Fade to black

...seek accelerated approval of Opdivo nivolumab in combination with Yervoy ipilimumab to treat lung cancer Cempra Inc....
...Inc. (NYSE:MRK) Solithera solithromycin fails in the Phase III SOLITAIRE-U trial to treat gonorrhea, and Cempra...
BioCentury | Mar 3, 2017
Clinical News

Oral Solithera: Ph III SOLITAIRE-U data

...evaluable population, Solithera led to a 91.3% success rate vs. 100% for ceftriaxone plus azithromycin. Cempra...
...Research and Development Agreement (CRADA). The expansion is enrolling up to 76 women and adolescents. Cempra...
...rights outside countries in the Association of Southeast Asian Nations (ASEAN) to solithromycin from Merck. Cempra Inc....
Items per page:
1 - 10 of 161
BioCentury | Dec 17, 2018
Company News

Management tracks: Vertex’s Graney joins Generation Bio

...He is succeeded as president and CEO by David Zaccardelli, who was acting CEO of Cempra Inc....
BioCentury | Jun 1, 2018
Financial News

Melinta closes $123.2M follow-on

...year. Melinta became a publicly traded company in November 2017 via a reverse merger with Cempra Inc....
BioCentury | May 24, 2018
Financial News

Melinta raises $110M in follow-on

...year. Melinta became a publicly traded company in November 2017 via a reverse merger with Cempra Inc....
BioCentury | Jan 31, 2018
Company News

Management tracks: Ipsen, Dragonfly

...disease company Dova Pharmaceuticals Inc. (NASDAQ:DOVA) hired Mark Hahn as CFO. He was CFO of Cempra Inc....
BioCentury | Nov 2, 2017
Company News

Management tracks: Melinta, Lundbeck

...Bluth was EVP of investor relations and corporate communications at Cempra Inc. (NASDAQ:CEMP). Melinta is acquiring Cempra...
BioCentury | Aug 11, 2017
Company News

Melinta goes public by acquiring majority of Cempra

...found a path to becoming public by acquiring a majority stake of fellow infectious company Cempra Inc....
...shareholders will own approximately 52% of the combined company; Cempra shareholders will own the remainder. Cempra...
...companies said Cempra is looking for non-dilutive funding to support a safety trial for Solithera. Cempra Inc....
BioCentury | Aug 9, 2017
Company News

Melinta goes public by acquiring majority of Cempra

...found a path to becoming public by acquiring a majority stake of fellow infectious company Cempra Inc....
...shareholders will own approximately 52% of the combined company; Cempra shareholders will own the remainder. Cempra...
...trial for Solithera. Cempra lost $0.15 to $3.65 on Wednesday. Elizabeth S. Eaton IV delafloxacin IV Solithera Oral delafloxacin Oral Solithera Cempra Inc. Melinta...
BioCentury | May 19, 2017
Clinical News

Cempra withdraws Solithera MAA

...EMA will require additional data for approval. FDA issued complete response letters in December for Cempra’s...
...company plans to resubmit both applications with the additional data requested by FDA. In February, Cempra...
...letter and discussions with FDA (see BioCentury, March 6 ). Solithera is a fluoroketolide/macrolide antibiotic. Cempra...
BioCentury | Apr 7, 2017
Finance

Fade to black

...seek accelerated approval of Opdivo nivolumab in combination with Yervoy ipilimumab to treat lung cancer Cempra Inc....
...Inc. (NYSE:MRK) Solithera solithromycin fails in the Phase III SOLITAIRE-U trial to treat gonorrhea, and Cempra...
BioCentury | Mar 3, 2017
Clinical News

Oral Solithera: Ph III SOLITAIRE-U data

...evaluable population, Solithera led to a 91.3% success rate vs. 100% for ceftriaxone plus azithromycin. Cempra...
...Research and Development Agreement (CRADA). The expansion is enrolling up to 76 women and adolescents. Cempra...
...rights outside countries in the Association of Southeast Asian Nations (ASEAN) to solithromycin from Merck. Cempra Inc....
Items per page:
1 - 10 of 161